India export diversification urged amid US tariffs
Analysis based on 7 articles · First reported Aug 20, 2026 · Last updated Aug 20, 2026
The event signals rising trade policy uncertainty for India's export sector, potentially pressuring textiles and pharmaceutical companies. However, the European trade agreements may offset some negative impact by diversifying export markets and improving competitiveness.
In the minutes of the State Bank of India's August policy meeting, Monetary Policy Committee member Rajesh Kumar urged India to urgently diversify its export markets amid growing US tariff risks. Kumar noted that the US accounts for one-fifth of India's exports and about one-third of labour-intensive exports such as textiles and garments. The US has imposed a 10% tariff on top of Most Favoured Nation tariffs on Indian exports due to forced labour concerns, and a Section 301 investigation is ongoing for excess capacity. Kumar also flagged future tariffs on generic drug imports: 100% from 2028 and 200% from 2029. He highlighted geopolitical risks including the West Asia conflict and the blockade of the Strait of Hormuz. To mitigate these risks, he pointed to recent trade agreements with European countries: FTAs with the European Free Trade Association and the United Kingdom are in force, and the agreement with the European Union, signed on January 27, 2026, is expected to come into force by end of 2026. These agreements could provide a level playing field for Indian exports in Europe versus Vietnam and Bangladesh, helping reduce dependence on the US market.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard